MEP54208A - Medicaments containing steroids and a novel anticholinesterase drug - Google Patents

Medicaments containing steroids and a novel anticholinesterase drug

Info

Publication number
MEP54208A
MEP54208A MEP-542/08A MEP54208A MEP54208A ME P54208 A MEP54208 A ME P54208A ME P54208 A MEP54208 A ME P54208A ME P54208 A MEP54208 A ME P54208A
Authority
ME
Montenegro
Prior art keywords
medicaments containing
containing steroids
novel
anticholinesterase drug
novel anticholinesterase
Prior art date
Application number
MEP-542/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Rolf Banholzer
Christopher John Montague Meade
Helmut Meissner
Gerd Morschhaeuser
Michel Pairet
Michael P Pieper
Gerald Pohl
Richard Reichl
Georg Speck
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MEP54208A publication Critical patent/MEP54208A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dispersion Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MEP-542/08A 2002-04-12 2003-04-09 Medicaments containing steroids and a novel anticholinesterase drug MEP54208A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10216429A DE10216429A1 (de) 2002-04-12 2002-04-12 Arzneimittel enthaltend Steroide und ein neues Anticholinergikum
PCT/EP2003/003668 WO2003086399A1 (de) 2002-04-12 2003-04-09 Arzneimittel enthaltend steroide und ein neues anticholinergikum
YUP-899/04A RS50776B (sr) 2002-04-12 2003-04-09 Medikamenti koji sadrže steroide i novi lek antiholinesteraze

Publications (1)

Publication Number Publication Date
MEP54208A true MEP54208A (en) 2011-05-10

Family

ID=28458802

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-542/08A MEP54208A (en) 2002-04-12 2003-04-09 Medicaments containing steroids and a novel anticholinesterase drug

Country Status (29)

Country Link
EP (2) EP1496902B1 (ko)
JP (1) JP4559086B2 (ko)
KR (1) KR101010869B1 (ko)
CN (1) CN1646126A (ko)
AR (1) AR039275A1 (ko)
AT (1) ATE312607T1 (ko)
AU (1) AU2003216921B2 (ko)
BR (1) BR0309085A (ko)
CA (1) CA2481268C (ko)
DE (2) DE10216429A1 (ko)
DK (1) DK1496902T3 (ko)
EA (1) EA008386B1 (ko)
EC (1) ECSP045355A (ko)
ES (1) ES2254917T3 (ko)
HR (1) HRP20040943B1 (ko)
IL (2) IL164391A0 (ko)
ME (1) MEP54208A (ko)
MX (1) MXPA04009917A (ko)
MY (1) MY137045A (ko)
NO (1) NO20044097L (ko)
NZ (1) NZ536284A (ko)
PE (1) PE20040326A1 (ko)
PL (1) PL211227B1 (ko)
RS (1) RS50776B (ko)
TW (1) TWI311055B (ko)
UA (1) UA80125C2 (ko)
UY (1) UY27758A1 (ko)
WO (1) WO2003086399A1 (ko)
ZA (1) ZA200406751B (ko)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
JP4819699B2 (ja) * 2004-02-06 2011-11-24 メダ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディト ゲゼルシャフト 喘息及びｃｏｐｄの長期間の治療のための抗コリン作用薬及びグルココルチコイドの組合せ剤
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
AU2010253776B2 (en) 2009-05-29 2015-01-22 Pearl Therapeutics, Inc. Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting B2 adrenergic receptor agonists and associated methods and systems
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
WO2014144894A1 (en) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
CN115282411A (zh) * 2022-01-14 2022-11-04 温州医科大学 利用鼻嗅区递送药物入脑的输送系统及其应用方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4570630A (en) 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
GR861995B (en) 1985-07-30 1986-11-04 Glaxo Group Ltd Devices for administering medicaments to patients
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE4108393A1 (de) 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
IL107120A (en) 1992-09-29 1997-09-30 Boehringer Ingelheim Int Atomising nozzle and filter and spray generating device
DE4318455A1 (de) 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
KR19990008109A (ko) * 1995-04-28 1999-01-25 나가사까 겐지로 1,4-이치환 피페리딘 유도체
DE19536903C2 (de) 1995-10-04 1998-09-10 Boehringer Ingelheim Int Vorrichtung zum Haltern eines fluidischen Bauteils
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
DE19545226C1 (de) 1995-12-05 1997-06-19 Boehringer Ingelheim Int Sperrspannwerk für einen federbetätigten Abtrieb
GB0009591D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medical combinations
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
AU2002210575A1 (en) * 2000-10-31 2002-05-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel medicament compositions based on anticholinergics and corticosteroids

Also Published As

Publication number Publication date
TWI311055B (en) 2009-06-21
MXPA04009917A (es) 2004-12-07
NO20044097L (no) 2004-11-04
HRP20040943A2 (en) 2005-04-30
MY137045A (en) 2008-12-31
BR0309085A (pt) 2005-02-09
CN1646126A (zh) 2005-07-27
UA80125C2 (en) 2007-08-27
CA2481268C (en) 2011-07-12
TW200403062A (en) 2004-03-01
EP1621197A2 (de) 2006-02-01
PL211227B1 (pl) 2012-04-30
KR20050000391A (ko) 2005-01-03
ES2254917T3 (es) 2006-06-16
EP1496902B1 (de) 2005-12-14
AU2003216921B2 (en) 2008-03-13
AU2003216921A1 (en) 2003-10-27
UY27758A1 (es) 2003-11-28
PE20040326A1 (es) 2004-07-13
EP1496902A1 (de) 2005-01-19
RS50776B (sr) 2010-08-31
JP2005529105A (ja) 2005-09-29
RS89904A (en) 2006-10-27
HRP20040943B1 (hr) 2013-05-31
PL371561A1 (en) 2005-06-27
ZA200406751B (en) 2006-12-27
DK1496902T3 (da) 2006-05-08
AR039275A1 (es) 2005-02-16
DE50301934D1 (de) 2006-01-19
NZ536284A (en) 2006-11-30
CA2481268A1 (en) 2003-10-23
ATE312607T1 (de) 2005-12-15
KR101010869B1 (ko) 2011-01-26
EA008386B1 (ru) 2007-04-27
EP1621197A3 (de) 2010-01-06
IL164391A (en) 2010-11-30
IL164391A0 (en) 2005-12-18
DE10216429A1 (de) 2003-10-23
WO2003086399A1 (de) 2003-10-23
JP4559086B2 (ja) 2010-10-06
EA200401303A1 (ru) 2005-04-28
ECSP045355A (es) 2005-01-28

Similar Documents

Publication Publication Date Title
MEP36608A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
BR0308937A (pt) Compostos imidazo fundidos
NO20032111L (no) Nye medikamentblandinger basert pa tiotropium-salter og pa salmeterol-salter
MEP10408A (en) Platinum derivative pharmaceutical formulations
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
TW200607799A (en) Therapeutic compounds: pyridine as scaffold
BR0309185A (pt) Medicamento contendo beta-miméticos e um novo anticolinérgico
UY26992A1 (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinérgicos y corticoesteroides
BRPI0513287A (pt) derivados de pirido-pirimidina, sua preparação, sua aplicação em terapêutica
UY27759A1 (es) Combinaciones de medicamentos que contienen compuestos heterocíclicos y un nuevo agente anticolinérgico.
MEP54208A (en) Medicaments containing steroids and a novel anticholinesterase drug
BR0210912A (pt) Compostos e composições como inibidores de catepsina
BRPI0408689B8 (pt) derivados de benzenosulfonamida, método para preparação e utilização disso para o tratamento da dor
BR0314261A (pt) Compostos, processo de preparação de um composto, composição farmacêutica que compreende o mesmo, utilização de um composto, método para tratamento e/ou profilaxia de enfermidades e utilização e/ou método de tratamento
BRPI0416136A (pt) processo para a produção de sais de tiotrópio, sais de tiotrópio, bem como formulações de medicamentos contendo os mesmos
BR0307703A (pt) Composições de medicamentos na base de agentes anticolinérgicos e inibidores de quinase de egfr
SE0101978D0 (sv) New compounds
BRPI0506702A (pt) composto, uso do mesmo, composição farmacêutica, método para a terapia de dor, e de distúrbios gatrointestinais funcionais em um animal de sangue quente, e, processo para preparar um composto
BRPI0511523A (pt) derivados de tioéter, processo para preparação dos mesmos, composição farmacêutica e uso dos referidos derivados
ATE452639T1 (de) Arzneimittelkompositionen aus tiotropiumsalzen und epinastin zur therapie von atemswegserkrankungen
MEP39708A (en) New pharmaceutical compositions containing epinastine and pseudoephedrine
EA200401302A1 (ru) Лекарственные средства, содержащие бетамиметики и новое антихолинергическое средство
DK1581224T3 (da) Tiotropiumholdig lægemiddelsammensætning til inhalation
BRPI0408521A (pt) composto, uso do mesmo, composição farmacêutica, métodos para a terapia da dor e distúrbios gastrointestinais fucionais em um animal de sangue quente, e, processo para preparar um composto
BRPI0506695A (pt) composto, uso do mesmo, composição farmacêutica, métodos para a terapia de dor, e de distúrbios gastrointestinais funcionais em um animal de sangue quente, e, processo para preparar um composto